Dosage form for administering calcium antagonist nicardipine

Details Dosage form for administering calcium antagonist nicardipine Dosage form for administering calcium antagonist nicardipine

1990-05-18

1992-03-17

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424472, 424484, A61K 924

Patent

active

050967169

ABSTRACT:
A dosage form is disclosed comprising a member selected from the group consisting of nicardipine and its pharmaceutically acceptable salts for administering to a patient in need of cardiovascular therapy.

REFERENCES:
patent: 2799241 (1957-06-01), Wurster
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4063064 (1977-12-01), Saunders et al.
patent: 4088864 (1978-05-01), Theeuwes et al.
patent: 4200098 (1980-04-01), Ayer et al.
patent: 4285987 (1981-08-01), Ayer et al.
patent: 4783337 (1988-11-01), Wong et al.
patent: 4892778 (1990-01-01), Theeuwes et al.

Affiliated with

Also associated with

Rating

Dosage form for administering calcium antagonist nicardipine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dosage form for administering calcium antagonist nicardipine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage form for administering calcium antagonist nicardipine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1474652